Comprehensive genomic profiling of gastric cancer to reveal distinctive genomic alterations between peritoneal metastasis (PM) patients (pts) and non-PM pts.

PD-L1 expression of 742 newly diagnosed advanced respiratory and digestive system tumours in China based on SP142 assay

PD-L1 expression and TMB status in newly diagnosed metastatic non-small cell lung cancer and their effect on prognosis after EGFR-TKI or platinum-based chemotherapy

Comparative genomic profiling of distant metastatic and nondistant metastatic lung adenocarcinoma

Genomic alterations across six hepatocellular carcinoma cell lines by panel-based sequencing